Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 10, 2014

View Archived Issues

Mechanistic characterization of a dual function anti-inflammatory and proapoptotic drug

Preclinical development of AIC-649 as a new strategy for the treatment of chronic viral infections

Synageva provides enrollment updates on studies of enzyme replacement therapy for LAL deficiency

Eddingpharm acquires rights to several oncology assets from ACT Biotech

FDA accepts LabCorp's IDE for companion diagnostic test for ARCA biopharma's Gencaro

Apitope-led consortium receives funding to develop therapeutic vaccine for Graves' disease

Labrys Biologics begins two phase II studies of LBR-101 in chronic and episodic migraine

SOM-0226 receives FDA orphan drug designation for transthyretin amyloidosis

Targazyme presents data for ASC-101, a human recombinant enzyme-based therapy

IGN-532 shows preclinical efficacy in xenograft models of AML

Leica Biosystems to develop companion diagnostic for Arno's targeted oncology therapy onapristone

Proteon obtains E.U. orphan drug status for PRT-201 for hemodialysis vascular access

Neumedicines' HemaMax shown to improve survival outcomes following lethal irradiation

FDA approves Isentress pediatric oral suspension

Adheron Therapeutics reports phase I data for SDP-051

EMA grants accelerated review to Bristol-Myers' MAA for daclatasvir in chronic HCV

Fenfluramine obtains orphan drug designation in the U.S. and E.U. for Dravet syndrome

FLINT trial stopped early for efficacy in NASH

The Mayo Foundation discloses new STAT3 inhibitors for cancer

Aggredyne gains FDA clearance for AggreGuide A-100 instrument and AA Assay

Sanofi prepares novel dual GLP-1 and GL-R agonists

Chinese researchers disclose novel antimycobacterial agents

Sage Therapeutics synthesizes novel GABA(A) receptor modulators

Five Prime Therapeutics enters into antibody collaboration with Adimab

Hangzhou Bensheng Pharmaceutical patents new saponins for cancer

Crystal Bioscience and Boehringer Ingelheim enter therapeutic antibody collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...